Atlas Trials

Breast Cancer Active Surveillance, Alternative Option, Aspirin Included

Clinical trial NCT03491410 · UNKNOWN

Trial details

NCT number
NCT03491410
Sponsor
Centro Hospitalar Lisboa Ocidental
Status
UNKNOWN
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Breast Cancer
Start date
2018-06-01
Primary completion
2019-12-31
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.